Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Pasithea Therapeutics Corp. (KTTA) had Return on Tangible Equity of -73.99% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.04M |
|
-- |
|
-- |
|
$3.11M |
|
$-3.11M |
|
$0.07M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.11M |
|
$-2.93M |
|
7.44M |
|
7.44M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$5.53M |
|
-- |
|
$8.10M |
|
$13.63M |
|
$1.38M |
|
-- |
|
$0.05M |
|
$1.42M |
|
$12.21M |
|
$4.11M |
|
$12.21M |
|
7.44M |
|
| Cash Flow Statement Financials | |
$-9.81M |
|
-- |
|
$7.10M |
|
$6.92M |
|
$4.22M |
|
$-2.70M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.88% |
|
|
Return on Tangible Equity |
-73.99% |
-22.28% |
|
-24.88% |
|
$1.64 |
|
$-1.32 |
|
$-1.32 |
|